Coronavirus Update - 14th October 2020

Despite the recent rises in Covid-19 cases throughout the UK and Europe, Arcinova remains open for business at full capacity as we have done throughout this pandemic. As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

Take pharmaceutical development to the next level

About Us

Fast forward to market with Arcinova

Our Services

For smarter, faster results, just add Arcinova

Contact Us

 

Ranked Number 9 in the

Alantra Pharma Fast 50

Latest news:

We are a Fastest50 company!

Find out more

Have you signed up to our newsletter?

Sign Up Here

AN INTRODUCTION TO ARCINOVA

We are an agile and flexible Contract Development and Manufacturing Organisation (CDMO) that serves pharmaceutical and biotechnology companies across the globe. We offer a wide range of services from our world-class 15,000m2 facility situated in the North of England. Having a breadth of expertise under one roof enables us to deliver a collaborative approach to the development and manufacture of drug substance and drug products. With decades of experience, we are helping companies to develop life changing medicines and take them to market quickly and efficiently.

READ MORE

What Customers Said

Latest News

Arcinova announces major investment in Alnwick site with the installation of the R1000 capsule fill machine from 3P Innovation

Read More

Arcinova Increases LC-MS/MS Capability with Addition of Sciex 6600 Triple TOF Mass Spectrometer

Read More

New case study released: Bringing the Manufacturing Process to Life Adapting from Terminal Sterilisation to Aseptic Manufacture

Read More

Accelerated Formulation Case Study Released

Read More